Management, functional outcomes and survival in a French multicentric series of 118 adult patients with cerebellar glioblastoma
Authors:
- French Brain Tumor DataBaseFDFrench Brain Tumor DataBase
- Thiébaud PicartTPThiébaud Picart
- Club de Neuro-Oncologie of the Société Française de NeurochirurgieCNClub de Neuro-Oncologie of the Société Française de Neurochirurgie
- David MeyronetDMDavid Meyronet
- Johan PalludJPJohan Pallud
- Philippe MetellusPMPhilippe Metellus
- Sonia ZouaouiSZSonia Zouaoui
- Moncef BerhoumaMBMoncef Berhouma
- François DucrayFDFrançois Ducray
- Luc BauchetLBLuc Bauchet
- 5 January 2021
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 147 (6) , 1843-1856
Abstract
Purpose To analyze the outcomes and predictors in a large series of cerebellar glioblastomas in order to guide patient management. Methods The French brain tumor database and the Club de Neuro-Oncologie of the Société Française de Neurochirurgie retrospectively identified adult patients with cerebellar glioblastoma diagnosed between 2003 and 2017. Diagnosis was confirmed by a centralized neuropathological review. Results Data from 118 cerebellar glioblastoma patients were analyzed (mean age 55.9 years, 55.1% males). The clinical presentation associated raised intracranial pressure (50.8%), static cerebellar syndrome (68.6%), kinetic cerebellar syndrome (49.2%) and/or cranial nerve disorders (17.8%). Glioblastomas were hemispheric (55.9%), vermian (14.4%) or both (29.7%). Hydrocephalus was present in 49 patients (41.5%). Histologically, tumors corresponded either to IDH-wild-type or to K27-mutant glioblastomas. Surgery consisted of total (12.7%), subtotal (35.6%), partial resection (33.9%) or biopsy (17.8%). The postoperative Karnofsky performance status was improved, stable and worsened in 22.4%, 43.9% and 33.7% of patients, respectively. Progression-free and overall survivals reached 5.1 months and 9.1 months, respectively. Compared to other surgical strategies, total or subtotal resection improved the Karnofsky performance status (33.3% vs 12.5%, p < 0.001), prolonged progression-free and overall survivals (6.5 vs 4.3 months, p = 0.015 and 16.7 vs 6.2 months, p < 0.001, respectively) and had a comparable complication rate (40.4% vs 31.1%, p = 0.29). After total or subtotal resection, the functional outcomes were correlated with age (p = 0.004) and cerebellar hemispheric tumor location (p < 0.001) but not brainstem infiltration (p = 0.16). Conclusion In selected patients, maximal resection of cerebellar glioblastoma is associated with improved onco-functional outcomes, compared with less invasive procedures.Keywords
This publication has 54 references indexed in Scilit:
- Recensement national histologique des tumeurs primitives du système nerveux central : résultats généraux sur 40 000 cas, principales applications actuelles et perspectivesNeurochirurgie, 2012
- An extent of resection threshold for newly diagnosed glioblastomasJournal of Neurosurgery, 2011
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working GroupJournal of Clinical Oncology, 2010
- Radiopathological characteristics of cerebellar malignant glioma in adultsBrain Tumor Pathology, 2009
- The influence of focal cerebellar lesions on the control and adaptation of gaitBrain, 2008
- Prognostic Factors for Survival in Adult Patients With Recurrent Glioma Enrolled Onto the New Approaches to Brain Tumor Therapy CNS Consortium Phase I and II Clinical TrialsJournal of Clinical Oncology, 2007
- Functional recovery of children and adolescents after cerebellar tumour resectionBrain, 2005
- A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survivalJournal of Neurosurgery, 2001
- Early Postoperative Magnetic Resonance Imaging after Resection of Malignant Glioma: Objective Evaluation of Residual Tumor and Its Influence on Regrowth and PrognosisNeurosurgery, 1994
- Poorly differentiated gliomas of the cerebellum. A study of 18 patientsCancer, 1990